This copy is for your personal, non-commercial use only. To order presentation-ready copies for distribution to your colleagues, clients or customers visit http://www.djreprints.com.
Updated Aug. 2, 2022 7:13 pm ET / Original Aug. 2, 2022 5:15 pm ET
- Order Reprints
- Print Article
As the U.S. prepares for a broad Covid-19 booster campaign this fall, investors are watching Moderna earnings on Wednesday to gauge how the company will hold up in an increasingly competitive market.
The Covid-19 vaccine maker (ticker: MRNA) is scheduled to report its earnings before the market opens. The company is holding an investor call at 8 a.m. Eastern.